tiprankstipranks
Trending News
More News >
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
US Market

Surgery Partners (SGRY) Ratios

Compare
380 Followers

Surgery Partners Ratios

SGRY's free cash flow for Q4 2025 was $0.24. For the 2025 fiscal year, SGRY's free cash flow was decreased by $ and operating cash flow was $0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.87 1.87 1.79 1.71 1.87
Quick Ratio
1.71 1.71 1.65 1.57 1.72
Cash Ratio
0.39 0.39 0.43 0.37 0.57
Solvency Ratio
0.02 0.02 >-0.01 0.03 0.02
Operating Cash Flow Ratio
0.45 0.45 0.48 0.56 0.32
Short-Term Operating Cash Flow Coverage
1.93 1.93 2.96 4.01 2.53
Net Current Asset Value
$ -3.56B$ -3.56B$ -3.14B$ -2.62B$ -2.48B
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.49 0.47 0.45 0.44
Debt-to-Equity Ratio
2.35 2.35 2.07 1.54 1.47
Debt-to-Capital Ratio
0.70 0.70 0.67 0.61 0.59
Long-Term Debt-to-Capital Ratio
0.61 0.61 0.65 0.58 0.56
Financial Leverage Ratio
4.81 4.81 4.41 3.46 3.34
Debt Service Coverage Ratio
1.17 1.32 1.21 1.68 1.47
Interest Coverage Ratio
0.59 1.43 1.73 1.70 1.47
Debt to Market Cap
1.78 1.45 1.26 0.69 1.02
Interest Debt Per Share
36.81 33.78 30.96 25.91 34.42
Net Debt to EBITDA
3.98 6.69 6.85 6.42 5.75
Profitability Margins
Gross Profit Margin
23.12%23.12%23.94%23.60%22.64%
EBIT Margin
23.41%11.77%11.20%11.96%13.59%
EBITDA Margin
28.73%17.09%16.10%16.26%18.12%
Operating Profit Margin
11.77%11.77%11.20%11.96%13.59%
Pretax Profit Margin
3.53%3.53%4.72%4.92%4.34%
Net Profit Margin
-2.35%-2.35%-5.40%-0.43%-2.15%
Continuous Operations Profit Margin
2.99%2.99%0.40%4.93%3.43%
Net Income Per EBT
-66.64%-66.64%-114.28%-8.81%-49.50%
EBT Per EBIT
30.01%30.01%42.17%41.16%31.95%
Return on Assets (ROA)
-0.95%-0.95%-2.13%-0.17%-0.82%
Return on Equity (ROE)
-4.50%-4.55%-9.39%-0.60%-2.73%
Return on Capital Employed (ROCE)
5.11%5.11%4.80%5.16%5.58%
Return on Invested Capital (ROIC)
4.24%4.24%0.40%5.07%4.33%
Return on Tangible Assets
-2.59%-2.59%-6.05%-0.48%-2.18%
Earnings Yield
-4.95%-3.96%-6.30%-0.30%-2.13%
Efficiency Ratios
Receivables Turnover
5.49 5.49 5.38 5.53 5.56
Payables Turnover
12.19 12.19 11.35 12.20 12.96
Inventory Turnover
26.33 26.33 26.80 27.87 27.51
Fixed Asset Turnover
2.29 2.29 2.25 2.24 2.20
Asset Turnover
0.40 0.40 0.39 0.40 0.38
Working Capital Turnover Ratio
6.29 6.42 7.18 6.86 6.07
Cash Conversion Cycle
50.35 50.35 49.33 49.22 50.69
Days of Sales Outstanding
66.43 66.43 67.87 66.05 65.59
Days of Inventory Outstanding
13.86 13.86 13.62 13.10 13.27
Days of Payables Outstanding
29.95 29.95 32.16 29.92 28.17
Operating Cycle
80.29 80.29 81.49 79.14 78.86
Cash Flow Ratios
Operating Cash Flow Per Share
2.16 2.16 2.38 2.34 1.73
Free Cash Flow Per Share
1.54 1.54 1.66 1.63 0.85
CapEx Per Share
0.62 0.62 0.72 0.71 0.88
Free Cash Flow to Operating Cash Flow
0.71 0.71 0.70 0.70 0.49
Dividend Paid and CapEx Coverage Ratio
3.49 3.49 3.32 3.31 1.97
Capital Expenditure Coverage Ratio
3.49 3.49 3.32 3.31 1.97
Operating Cash Flow Coverage Ratio
0.07 0.07 0.08 0.10 0.05
Operating Cash Flow to Sales Ratio
0.08 0.08 0.10 0.11 0.06
Free Cash Flow Yield
12.23%9.95%7.85%5.10%3.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-20.18 -25.23 -15.88 -337.68 -46.92
Price-to-Sales (P/S) Ratio
0.48 0.59 0.86 1.46 1.01
Price-to-Book (P/B) Ratio
0.92 1.15 1.49 2.02 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
8.18 10.05 12.73 19.60 32.76
Price-to-Operating Cash Flow Ratio
5.73 7.17 8.90 13.68 16.13
Price-to-Earnings Growth (PEG) Ratio
-0.37 0.47 -0.01 4.02 0.99
Price-to-Fair Value
0.92 1.15 1.49 2.02 1.28
Enterprise Value Multiple
5.66 10.17 12.17 15.43 11.32
Enterprise Value
5.38B 5.75B 6.10B 6.88B 5.21B
EV to EBITDA
5.66 10.17 12.17 15.43 11.32
EV to Sales
1.63 1.74 1.96 2.51 2.05
EV to Free Cash Flow
27.53 29.40 29.11 33.58 66.61
EV to Operating Cash Flow
19.63 20.96 20.34 23.43 32.80
Tangible Book Value Per Share
-13.43 -13.43 -11.72 -8.11 -9.75
Shareholders’ Equity Per Share
13.47 13.47 14.19 15.82 21.73
Tax and Other Ratios
Effective Tax Rate
0.15 0.15 0.92 >-0.01 0.21
Revenue Per Share
26.01 26.01 24.69 21.84 27.62
Net Income Per Share
-0.61 -0.61 -1.33 -0.09 -0.59
Tax Burden
-0.67 -0.67 -1.14 -0.09 -0.50
Interest Burden
0.15 0.30 0.42 0.41 0.32
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.16 0.16 0.04 0.04 0.04
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 <0.01 <0.01
Income Quality
10.97 2.77 24.01 2.17 1.83
Currency in USD